Management of the patient with incomplete response to PPI therapy

Kahrilas, 2008, AGAI medical position statement: management of gastroesophageal reflux disease, Gastroenterology, 135, 1383, 10.1053/j.gastro.2008.08.045 Numans, 2004, Short-term treatment with proton-pump inhibitors as a test for gastroesophageal reflux disease: a meta-analysis of diagnostic test characteristics, Ann Intern Med, 140, 518, 10.7326/0003-4819-140-7-200404060-00011 Kahrilas, 1997, Treatment vs management of gastroesophageal reflux disease, Am J Gastroenterol, 92, 1959 Vakil, 2006, The Montreal definition and classification of gastro-esophageal reflux disease (GERD) – a global evidence-based consensus, Am J Gastroenterol, 101, 1900, 10.1111/j.1572-0241.2006.00630.x Sandler, 2002, The burden of selected digestive diseases in the United States, Gastroenterology, 122, 1500, 10.1053/gast.2002.32978 Inadomi, 2003, Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs, Am J Gastroenterol, 98, 1940, 10.1111/j.1572-0241.2003.07665.x Dean, 2004, Effectiveness of proton pump inhibitors in nonerosive reflux disease, Clin Gastroenterol Hepatol, 2, 656, 10.1016/S1542-3565(04)00288-5 Kahrilas, 2012, Failure of reflux inhibitors in clinical trials: bad drugs or wrong patients?, Gut, 61, 1501, 10.1136/gutjnl-2011-301898 Jones, 2001, Hiatal hernia size is the dominant determinant of esophagitis presence and severity in gastroesophageal reflux disease, Am J Gastroenterol, 96, 1711, 10.1111/j.1572-0241.2001.03926.x Lin, 1994, Impaired esophageal emptying in reflux disease, Am J Gastroenterol, 89, 1003 Gillen, 1987, Barrett's oesophagus: pH profile, Br J Surg, 74, 774, 10.1002/bjs.1800740906 Singh, 1992, Oesophageal motor function before and after healing of oesophagitis, Gut, 33, 1590, 10.1136/gut.33.12.1590 Mittal, 1987, Identification and mechanism of delayed esophageal acid clearance in subjects with hiatus hernia, Gastroenterology, 92, 130, 10.1016/0016-5085(87)90849-3 Sloan, 1991, Impairment of esophageal emptying with hiatal hernia, Gastroenterology, 100, 596, 10.1016/0016-5085(91)80003-R Smith, 2010, Acoustic cough-reflux associations in chronic cough: potential triggers and mechanisms, Gastroenterology, 139, 754, 10.1053/j.gastro.2010.06.050 Clouse, 2005, Use of psychopharmacological agents for functional gastrointestinal disorders, Gut, 54, 1332, 10.1136/gut.2004.048884 Vaezi, 2006, Treatment of chronic posterior laryngitis with esomeprazole, Laryngoscope, 116, 254, 10.1097/01.mlg.0000192173.00498.ba Kahrilas, 2011, Response of regurgitation to proton pump inhibitor therapy in clinical trials of gastroesophageal reflux disease, Am J Gastroenterol, 106, 1419, 10.1038/ajg.2011.146 Kahrilas, 2012, Regurgitation is less responsive to acid suppression than heartburn in patients with gastroesophageal reflux disease, Clin Gastroenterol Hepatol, 10, 612, 10.1016/j.cgh.2012.01.022 Kahrilas, 2011, Response of unexplained chest pain to proton pump inhibitor treatment in patients with and without objective evidence of gastro-oesophageal reflux disease, Gut, 60, 1473, 10.1136/gut.2011.241307 Chang, 2011, Cochrane Database Syst Rev, CD004823 Kahrilas, 2013, Response of chronic cough to acid-suppressive therapy in patients with gastroesophageal reflux disease, Chest, 143, 605, 10.1378/chest.12-1788 Dickman, 2011, Comparison of clinical characteristics of patients with gastroesophageal reflux disease who failed proton pump inhibitor therapy versus those who fully responded, J Neurogastroenterol Motil, 17, 387, 10.5056/jnm.2011.17.4.387 Bytzer, 2012, Partial symptom-response to proton pump inhibitors in patients with non-erosive reflux disease or reflux oesophagitis – a post hoc analysis of 5796 patients, Aliment Pharmacol Ther, 36, 635, 10.1111/apt.12007 Aanen, 2006, Diagnostic value of the Reflux Disease Questionnaire in general practice, Digestion, 74, 162, 10.1159/000100511 Miyamoto, 2010, Efficacy of the addition of prokinetics for proton pump inhibitor (PPI) resistant non-erosive reflux disease (NERD) patients: significance of frequency scale for the symptom of GERD (FSSG) on decision of treatment strategy, Intern Med, 49, 1469, 10.2169/internalmedicine.49.3615 Kahrilas, 2012, Concomitant symptoms itemized in the Reflux Disease Questionnaire are associated with attenuated heartburn response to acid suppression, Am J Gastroenterol, 107, 1354, 10.1038/ajg.2012.197 Lichtenstein, 2007, Role of endoscopy in the management of GERD, Gastrointest Endosc, 66, 219, 10.1016/j.gie.2007.05.027 Poh, 2010, Upper GI tract findings in patients with heartburn in whom proton pump inhibitor treatment failed versus those not receiving antireflux treatment, Gastrointest Endosc, 71, 28, 10.1016/j.gie.2009.08.024 Shaheen, 2013, Esophageal mucosal breaks in gastroesophageal reflux disease partially responsive to proton pump inhibitor therapy, Am J Gastroenterol, 108, 529, 10.1038/ajg.2012.447 Ismail-Beigi, 1970, Histological consequences of gastroesophageal reflux in man, Gastroenterology, 58, 163, 10.1016/S0016-5085(70)80004-X Tobey, 1996, Dilated intercellular spaces: a morphological feature of acid reflux – damaged human esophageal epithelium, Gastroenterology, 111, 1200, 10.1053/gast.1996.v111.pm8898633 Vela, 2011, Refractory heartburn: comparison of intercellular space diameter in documented GERD vs. functional heartburn, Am J Gastroenterol, 106, 844, 10.1038/ajg.2010.476 Pandolfino, 2005, Comparison of the Bravo wireless and Digitrapper catheter-based pH monitoring systems for measuring esophageal acid exposure, Am J Gastroenterol, 100, 1466, 10.1111/j.1572-0241.2005.41719.x Hakanson, 2009, Comparison of wireless 48-h (Bravo) versus traditional ambulatory 24-h esophageal pH monitoring, Scand J Gastroenterol, 44, 276, 10.1080/00365520802588109 Wiener, 1988, The symptom index: a clinically important parameter of ambulatory 24-hour esophageal pH monitoring, Am J Gastroenterol, 83, 358 Weusten, 1994, The symptom-association probability: an improved method for symptom analysis of 24-hour esophageal pH data, Gastroenterology, 107, 1741, 10.1016/0016-5085(94)90815-X Galmiche, 2006, Functional esophageal disorders, Gastroenterology, 130, 1459, 10.1053/j.gastro.2005.08.060 Sifrim, 2001, Acid, nonacid, and gas reflux in patients with gastroesophageal reflux disease during ambulatory 24-hour pH-impedance recordings, Gastroenterology, 120, 1588, 10.1053/gast.2001.24841 Bredenoord, 2005, Determinants of perception of heartburn and regurgitation, Gut, 55, 313, 10.1136/gut.2005.074690 Hemmink, 2008, Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: ‘on’ or ‘off’ proton pump inhibitor?, Am J Gastroenterol, 103, 2446, 10.1111/j.1572-0241.2008.02033.x Kessing, 2011, Erroneous diagnosis of gastroesophageal reflux disease in achalasia, Clin Gastroenterol Hepatol, 9, 1020, 10.1016/j.cgh.2011.04.022 Ponce, 2011, High prevalence of heartburn and low acid sensitivity in patients with idiopathic achalasia, Dig Dis Sci, 56, 773, 10.1007/s10620-010-1343-x Bredenoord, 2007, Technology review: esophageal impedance monitoring, Am J Gastroenterol, 102, 187, 10.1111/j.1572-0241.2006.00966.x Hatlebakk, 2000, Proton pump inhibitors: better acid suppression when taken before a meal than without a meal, Aliment Pharmacol Ther, 14, 1267, 10.1046/j.1365-2036.2000.00829.x Gunaratnam, 2006, Sub-optimal proton pump inhibitor dosing is prevalent in patients with poorly controlled gastro-oesophageal reflux disease, Aliment Pharmacol Ther, 23, 1473, 10.1111/j.1365-2036.2006.02911.x Orlando, 2010, Relationship between esomeprazole dose and timing to heartburn resolution in selected patients with gastroesophageal reflux disease, Clin Exp Gastroenterol, 3, 117, 10.2147/CEG.S12333 Fass, 2006, Treatment of patients with persistent heartburn symptoms: a double-blind, randomized trial, Clin Gastroenterol Hepatol, 4, 50, 10.1016/S1542-3565(05)00860-8 Dent, 2008, A randomized, comparative trial of a potassium-competitive acid blocker (AZD0865) and esomeprazole for the treatment of patients with nonerosive reflux disease, Am J Gastroenterol, 103, 20, 10.1111/j.1572-0241.2007.01544.x Kahrilas, 2007, A randomized, comparative study of three doses of AZD0865 and esomeprazole for healing of reflux esophagitis, Clin Gastroenterol Hepatol, 5, 1385, 10.1016/j.cgh.2007.08.014 Leite, 1996, Persistent acid secretion during omeprazole therapy: a study of gastric acid profiles in patients demonstrating failure of omeprazole therapy, Am J Gastroenterol, 91, 1527 Mainie, 2008, Addition of a H2 receptor antagonist to PPI improves acid control and decreases nocturnal acid breakthrough, J Clin Gastroenterol, 42, 676, 10.1097/MCG.0b013e31814a4e5c Fackler, 2002, Long-term effect of H2RA therapy on nocturnal gastric acid breakthrough, Gastroenterology, 122, 625, 10.1053/gast.2002.31876 Vigneri, 1995, A comparison of five maintenance therapies for reflux esophagitis, N Engl J Med, 333, 1106, 10.1056/NEJM199510263331703 Miwa, 2011, Randomised clinical trial: efficacy of the addition of a prokinetic, mosapride citrate, to omeprazole in the treatment of patients with non-erosive reflux disease – a double-blind, placebo-controlled study, Aliment Pharmacol Ther, 33, 323, 10.1111/j.1365-2036.2010.04517.x Fletcher, 2001, Unbuffered highly acidic gastric juice exists at the gastroesophageal junction after a meal, Gastroenterology, 121, 775, 10.1053/gast.2001.27997 Beaumont, 2010, The position of the acid pocket as a major risk factor for acidic reflux in healthy subjects and patients with GORD, Gut, 59, 441, 10.1136/gut.2009.178061 Rohof, 2012, Effect of azithromycin on acid reflux, hiatus hernia and proximal acid pocket in the postprandial period, Gut, 61, 1670, 10.1136/gutjnl-2011-300926 Kahrilas, 2013, The acid pocket: a target for treatment in reflux disease?, Am J Gastroenterol, 10.1038/ajg.2013.132 Savarino, 2012, Alginate controls heartburn in patients with erosive and nonerosive reflux disease, World J Gastroenterol, 18, 4371, 10.3748/wjg.v18.i32.4371 Rohof, 2013, An alginate-antacid formulation localizes to the acid pocket to reduce acid reflux in patients with gastroesophageal reflux disease, Clin Gastroenterol Hepatol, 10.1016/j.cgh.2013.04.046 Manabe, 2012, Efficacy of adding sodium alginate to omeprazole in patients with nonerosive reflux disease: a randomized clinical trial, Dis Esophagus, 25, 373, 10.1111/j.1442-2050.2011.01276.x Chey, 2009, Treatment patterns and symptom control in patients with GERD: US community-based survey, Curr Med Res Opin, 25, 1869, 10.1185/03007990903035745 Vela, 2003, Baclofen decreases acid and non-acid post-prandial gastro-oesophageal reflux measured by combined multichannel intraluminal impedance and pH, Aliment Pharmacol Ther, 17, 243, 10.1046/j.1365-2036.2003.01394.x Boeckxstaens, 2010, Systematic review: role of acid, weakly acidic and weakly alkaline reflux in gastro-oesophageal reflux disease, Aliment Pharmacol Ther, 32, 334, 10.1111/j.1365-2036.2010.04358.x Boeckxstaens, 2011, A novel reflux inhibitor lesogaberan (AZD3355) as add-on treatment in patients with GORD with persistent reflux symptoms despite proton pump inhibitor therapy: a randomised placebo-controlled trial, Gut, 60, 1182, 10.1136/gut.2010.235630 Shaheen, 2012, Efficacy and safety of lesogaberan in gastro-oesophageal reflux disease: a randomised controlled trial, Gut Koek, 2003, Effect of the GABA(B) agonist baclofen in patients with symptoms and duodeno-gastro-oesophageal reflux refractory to proton pump inhibitors, Gut, 52, 1397, 10.1136/gut.52.10.1397 Prakash, 1999, Long-term outcome from tricyclic antidepressant treatment of functional chest pain, Dig Dis Sci, 44, 2373, 10.1023/A:1026645914933 Clouse, 1987, Low-dose trazodone for symptomatic patients with esophageal contraction abnormalities. A double-blind, placebo-controlled trial, Gastroenterology, 92, 1027, 10.1016/0016-5085(87)90979-6 Broekaert, 2006, Influence of citalopram, a selective serotonin reuptake inhibitor, on oesophageal hypersensitivity: a double-blind, placebo-controlled study, Aliment Pharmacol Ther, 23, 365, 10.1111/j.1365-2036.2006.02772.x Dickman, 2007, Clinical trial: acupuncture vs. doubling the proton pump inhibitor dose in refractory heartburn, Aliment Pharmacol Ther, 26, 1333, 10.1111/j.1365-2036.2007.03520.x Nojkov, 2008, The influence of co-morbid IBS and psychological distress on outcomes and quality of life following PPI therapy in patients with gastro-oesophageal reflux disease, Aliment Pharmacol Ther, 27, 473, 10.1111/j.1365-2036.2008.03596.x Kiebles, 2010, Do patients with globus sensation respond to hypnotically assisted relaxation therapy? A case series report, Dis Esophagus, 23, 545, 10.1111/j.1442-2050.2010.01064.x Lundell, 2008, Comparing laparoscopic antireflux surgery with esomeprazole in the management of patients with chronic gastro-oesophageal reflux disease: a 3-year interim analysis of the LOTUS trial, Gut, 57, 1207, 10.1136/gut.2008.148833 Galmiche, 2011, Laparoscopic antireflux surgery vs esomeprazole treatment for chronic GERD. The LOTUS randomized clinical trial, J Am Med Assoc, 305, 1969, 10.1001/jama.2011.626 Vakil, 2003, Clinical effectiveness of laparoscopic fundoplication in a U.S. community, Am J Med, 114, 1, 10.1016/S0002-9343(02)01390-6 Hunter, 1999, Laparoscopic fundoplication failures: patterns of failure and response to fundoplication revision, Ann Surg, 230, 595, 10.1097/00000658-199910000-00015